CARIE BODNAR: Open Payments
NPI 1568071116 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,384 in 77 payments from 9 companies in 2025. Trend: 2023 $456 · 2024 $1,534 · 2025 $2,384
Food & beverage: $2,295Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $1,087 |
| GENZYME CORPORATION | 14 | $465 |
| Madrigal Pharmaceuticals | 15 | $339 |
| Janssen Scientific Affairs, LLC | 2 | $201 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $89 |
| Novo Nordisk Inc | 1 | $46 |
| EVOKE PHARMA, INC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: DUPIXENT, REZDIFFRA, SKYRIZI, TREMFYA, CREON, RINVOQ, LINZESS, ZENPEP.
Industry payments across TX — which companies pay providers there.
